Quality of life in patients with obstructive hypertrophic cardiomyopathy after percutaneous transluminal septal tunnel myocardial ablation and its influencing factors in a short time
10.3969/j.issn.1006-5725.2014.09.017
- VernacularTitle:经皮室间隔隧道化学消融术治疗肥厚梗阻型心肌病患者短期生存质量及影响因素的研究
- Author:
He WANG
;
Huaimin GUAN
;
Jinhong XIE
;
Yushan CHEN
;
Minghua LUO
;
Shuangshuang CHAI
- Publication Type:Journal Article
- Keywords:
Cardiomyopathy,hypertrophic;
Percutaneous transluminal septal tunnel myocardial ablation;
Quality of life
- From:
The Journal of Practical Medicine
2014;(9):1398-1400
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the short-term quality of life in patients with obstructive hypertrophic cardiomyopathy (OHCM) after percutaneous transluminal septal tunnel myocardial ablation (PTSTMA). Methods The quality of life in patients with OHCM were assessed by the SF-36 before and three months after PTSTMA. Results Three months after the procedure , quality of life was markedly improved at different variances in patients with OHCM as compared with the baseline. The linear regression analysis showed the factors influencing quality of life were character, coexistence with other diseases, and 6-minute walk test. Conclusions Percutaneous transluminal septal tunnel myocardial ablation can improve the short-term quality of life in patients with OHCM. Postoperative psychological counseling and rehabilitation guidance can practically enhance quality of life.
